MRI-guided chemo before surgery for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether using a special MRI scan to guide chemotherapy can help people with pancreatic cancer that is on the edge of being removable. The goal is to shrink the tumor enough for successful surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have been newly diagnosed with borderline resectable pancreatic cancer (tumor that may be removable after treatment).
- You have not had any chemotherapy, radiation, or surgery for pancreatic cancer before.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you are not planning to father a child during the study.
- You are able and willing to undergo MRI scans (no metal implants or other MRI safety issues).
- You have signed a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs (FOLFIRINOX and gemcitabine plus TAMP) given before surgery for borderline resectable pancreatic cancer. The goal is to shrink the tumor and make surgery more successful.
This trial tests a combination of chemotherapy drugs (irinotecan liposome, 5-FU, leucovorin, and oxaliplatin) given before and after surgery for people with pancreatic cancer that is on the border of being removable. The goal is to see if this treatment helps shrink the tumor and improve outcomes.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
Hear when a new Borderline Resectable Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.